Experimental evidence suggests that interplay between prostaglandins and both the renin-angiotensin and kallikrein-kinin systems may figure in normal blood pressure regulation. If, as seems reasonable, some forms of chronic hypertension can be explained by prostaglandin deficiency, eventually antihypertensive therapy might entail measures to enhance prostaglandin synthesis or impede enzymatic degradation.